NRT Smoking Cessation Aids in Germany
Euromonitor International's NRT Smoking Cessation Aids in Germany market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 45 | Publication date: Apr 2009
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
NRT gum; NRT inhalators; NRT lozenges; NRT patches; Other NRT
Table of contents
NRT SMOKING CESSATION AIDS IN GERMANY : MARKET INSIGHT
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR INDICATORS
Table 1 Number of Smokers by Gender 2003-2008
SECTOR DATA
Table 2 Sales of Smoking Cessation Aids by Subsector: Value 2003-2008
Table 3 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2003-2008
Table 4 NRT Gum Flavours: % Value Breakdown 2006-2008
Table 5 Smoking Cessation Aids Company Shares by Value 2004-2008
Table 6 Smoking Cessation Aids Brand Shares by Value 2005-2008
Table 7 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2008-2013
Table 8 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2008-2013
LOCAL COMPANY PROFILES - GERMANY
BEIERSDORF AG - OTC HEALTHCARE - GERMANY
STRATEGIC DIRECTION
KEY FACTS
Summary 1 Beiersdorf AG: Key Facts
Summary 2 Beiersdorf AG: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 3 Beiersdorf AG: Competitive Position 2008
BAYER VITAL GMBH - OTC HEALTHCARE - GERMANY
STRATEGIC DIRECTION
KEY FACTS
Summary 4 Bayer Vital AG: Key Facts
Summary 5 Bayer Vital AG: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 6 Bayer Vital AG: Production Statistics 2007
COMPETITIVE POSITIONING
Summary 7 Bayer Vital AG: Competitive Position 2008
BOEHRINGER INGELHEIM PHARMA GMBH & CO KG - OTC HEALTHCARE - GERMANY
STRATEGIC DIRECTION
KEY FACTS
Summary 8 Boehringer Ingelheim Pharma GmbH & Co KG: Key Facts
Summary 9 Boehringer Ingelheim Pharma GmbH & Co KG: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 10 Boehringer Ingelheim Pharma GmbH & Co KG: Competitive Position 2008
JOHNSON & JOHNSON GMBH - OTC HEALTHCARE - GERMANY
STRATEGIC DIRECTION
KEY FACTS
Summary 11 Johnson & Johnson GmbH: Key Facts
Summary 12 Johnson & Johnson GmbH: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 13 Johnson & Johnson GmbH: Competitive Position 2008
MCM KLOSTERFRAU VERTRIEBSGESELLSCHAFT MBH - OTC HEALTHCARE - GERMANY
STRATEGIC DIRECTION
KEY FACTS
Summary 14 MCM Klosterfrau Vertriebsgesellschaft mbH: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 15 MCM Klosterfrau Vertriebsgesellschaft mbH: Competitive Position 2008
NOVARTIS AG - OTC HEALTHCARE - GERMANY
STRATEGIC DIRECTION
KEY FACTS
Table 9 Novartis Consumer Health GmbH: Key Facts
Summary 16 Novartis Consumer Health GmbH: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 17 Novartis Consumer Health GmbH: Competitive Position 2008
RATIOPHARM GMBH & CO - OTC HEALTHCARE - GERMANY
STRATEGIC DIRECTION
KEY FACTS
Summary 18 Ratiopharm GmbH & Co: Key Facts
Summary 19 Ratiopharm GmbH & Co: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 20 Ratiopharm GmbH & Co: Competitive Position 2008
STADA ARZNEIMITTEL AG - OTC HEALTHCARE - GERMANY
STRATEGIC DIRECTION
KEY FACTS
Summary 21 STADA Arzneimittel AG: Key Facts
Summary 22 STADA Arzneimittel AG: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 23 STADA Arzneimittel AG: Competitive Position 2008
OTC HEALTHCARE IN GERMANY
EXECUTIVE SUMMARY
OTC healthcare – a stagnating market
Smoking ban drives NRT sales
Changing distribution system
Major brands gaining importance
Mixed outlook for OTC healthcare
KEY TRENDS AND DEVELOPMENTS
Economy stalls, no recovery expected over the medium term
The decline and ageing of Germany’s population continues
Germany’s changing OTC retail environment
Homeopathy gaining ground against herbal products
MARKET INDICATORS
Table 10 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 11 Life Expectancy at Birth 2003-2008
MARKET DATA
Table 12 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 13 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 14 OTC Healthcare Company Shares by Value 2004-2008
Table 15 OTC Healthcare Brand Shares by Value 2005-2008
Table 16 Penetration of Private Label by Sector 2003-2008
Table 17 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 18 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 19 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 20 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
APPENDIX
OTC Registration and Classification
Vitamins & Dietary Supplements Registration and Classification
EU Legislation
Self-medication and Preventative Medicine
Generics
Summary 24 OTC Healthcare Switches 2005-2007
DEFINITIONS
Summary 25 Research Sources